Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Clin Cancer Res. 2010 May 25;16(11):3057–3066. doi: 10.1158/1078-0432.CCR-10-0124

Figure 4.

Figure 4

Paired bar plot demonstrating peripheral blood mononuclear cell (PBMC) and prostate tumor phospho-S6 inhibition among those rapamycin-treated subjects (n=9) who had available PBMC and tumor tissue for biomarker assessment. Phospho-S6 percent change (before and after rapamycin) is calculated using the equation depicted in the figure.